Tg Therapeutics (TGTX) Selling, General & Administrative (2011 - 2026)

Tg Therapeutics (TGTX) Selling, General & Administrative (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -10.08 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 2.17 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 555.10 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 17.02 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -355.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 101.25 Mn
10 Tg Therapeutics 8.08 Bn 8.00 Bn 171.41 Mn 88.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 88.22 Mn
Dec 31, 2025 62.75 Mn
Sep 30, 2025 63.37 Mn
Jun 30, 2025 55.59 Mn
Mar 31, 2025 50.33 Mn
Dec 31, 2024 38.96 Mn
Sep 30, 2024 41.97 Mn
Jun 30, 2024 38.79 Mn
Mar 31, 2024 34.58 Mn
Dec 31, 2023 31.15 Mn
Sep 30, 2023 32.77 Mn
Jun 30, 2023 30.72 Mn
Mar 31, 2023 28.07 Mn
Dec 31, 2022 47.98 Mn
Sep 30, 2022 14.25 Mn
Jun 30, 2022 12.64 Mn
Mar 31, 2022 20.61 Mn
Dec 31, 2021 32.41 Mn
Sep 30, 2021 34.90 Mn
Jun 30, 2021 34.02 Mn